Trial Details

COMPLETED
Basic Information
Clinical ID c1789
Identifier NCT01988506
Trial Title Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Rheumatoid Arthritis|Ankylosing Spondylitis|Systemic Lupus Erythematosus|Psoriasis|Behcet's Disease|Wegener's Granulomatosis|Takayasu's Disease|Crohn's Disease|Ulcerative Colitis|Autoimmune Hepatitis|Sclerosing Cholangitis|Gougerot-sj枚gren|Idiopathic Thrombocytopenic Purpura|Systemic Sclerosis
Interventions DRUG: Interleukin 2
Participant Information
Sponsor Assistance Publique - H么pitaux de Paris
City Paris
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2014-01-06
Primary Completion Date 2019-10-16
Completion Date 2021-04-01